Navamedic ASA (N1A) Stock Statistics & Valuation Metrics

Navamedic ASA has a market cap or net worth of €36.98M. The enterprise value is €601.29.

Navamedic ASA has 23,981,379 shares outstanding. The number of shares has decreased by -2.65% in one year.

Navamedic ASA’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is 2.64%.

The current PE Ratio of Navamedic ASA is ―. Navamedic ASA’s PEG ratio is ―.

In the last 12 months, Navamedic ASA had revenue of 565.36M and earned -23.54M in profits. Earnings per share was -0.98.

In the last 12 months, operating cash flow was 13.89M and capital expenditures -2.37M, giving a free cash flow of 11.53M billion.

Navamedic ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Navamedic ASA upcoming earnings date is Aug 14, 2026, TBA (Confirmed).

Navamedic ASA as a current ratio of 1.55, with Debt / Equity ratio of 65.43%

In the past 12 months, Navamedic ASA has paid 7.88M in taxes.

Navamedic ASA EV to EBITDA ratio is 15.21, with an EV/FCF ratio of 31.20.

Navamedic ASA has €78.28M in cash and marketable securities with €139.93M in debt, giving a net cash position of -€126.46M billion.

Gross margin is 29.45%, with operating margin of 2.87%, and net profit margin of -4.16%.

The average price target for Navamedic ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―